Atlas Trials

Bioequivalence and Food Effect of 250mg of Lamotrigine XR

Clinical trial NCT00605371 · COMPLETED

Trial details

NCT number
NCT00605371
Sponsor
GlaxoSmithKline
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Epilepsy
Start date
2008-01-15
Primary completion
2008-03-06
Enrollment
209

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.